Financials (USD)
Sales 2024 * | 29.34M | Sales 2025 * | 90.7M | Capitalization | 191M |
---|---|---|---|---|---|
Net income 2024 * | -69M | Net income 2025 * | -20M | EV / Sales 2024 * | 7.08 x |
Net Debt 2024 * | 16.8M | Net Debt 2025 * | 14.8M | EV / Sales 2025 * | 2.27 x |
P/E ratio 2024 * |
-2.87
x | P/E ratio 2025 * |
-8.83
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.7% |
Latest transcript on KemPharm, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Christal Mickle
FOU | Founder | 45 | 06-10-29 |
Neil McFarlane
CEO | Chief Executive Officer | 51 | 23-10-09 |
R. Clifton
DFI | Director of Finance/CFO | 51 | 15-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wendy Dixon
BRD | Director/Board Member | 68 | 23-04-24 |
Tamara Favorito
CHM | Chairman | 65 | 21-08-17 |
Director/Board Member | 56 | 23-04-24 |
1st Jan change | Capi. | |
---|---|---|
+4.37% | 70.78B | |
+10.72% | 9.15B | |
-15.34% | 4.84B | |
+34.54% | 4.22B | |
+5.09% | 3.92B | |
+21.18% | 2.55B | |
-28.33% | 2.24B | |
-24.15% | 2.26B | |
+6.23% | 1.92B |